- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04983082
Portsmouth CORE-D Routine Care Data Repository (CORE-D)
April 6, 2023 updated by: Portsmouth Hospitals NHS Trust
Portsmouth Clinical Outcomes REsearch Database (CORE-D)- a Research Database of Routine Electronically Recorded Patient Data to Model Adverse Clinical Outcomes and Healthcare Resource Usage
An integrated database of depersonalised routine hospital patient data consisting of demographic and disease attributes, physiological or laboratory measurements, care contacts and interventions along with associated clinical outcomes.
The database is an essential resource for the development and testing of risk models and classification systems, modified as necessary for patient subgroups, which can then be introduced into clinical care to improve patient outcomes.
It can also be used for large scale simulations to evaluate interventions.
Study Overview
Status
Recruiting
Detailed Description
The aims and objectives of this database of depersonalised routinely collected hospital patient data are to:
- Conduct epidemiological and observational studies of acute hospital care.
- Develop and use algorithms and risk models to identify the deteriorating / sick adult so that interventions and enhanced care can be provided in a timelier manner with consequent resource and outcome improvements. This covers both the deteriorating inpatient at risk of adverse outcomes and people in the local community at risk of hospitalisation or in need of other health services.
- Retrospectively evaluate interventions e.g. impact of system-wide clinical pathway introduction
- Conduct simulations of clinical pathways
Study Type
Observational
Enrollment (Anticipated)
750000
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Paul Meredith, PhD
- Phone Number: 3774 023 92286000
- Email: paul.meredith@porthosp.nhs.uk
Study Contact Backup
- Name: Alice Mortlock, PhD
- Phone Number: 4042 023 92286000
- Email: alice.mortlock@porthosp.nhs.uk
Study Locations
-
-
Hampshire
-
Portsmouth, Hampshire, United Kingdom, PO6 3LY
- Recruiting
- Queen Alexandra Hospital
-
Contact:
- Paul E Schmidt
-
Principal Investigator:
- Paul E Schmidt
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years and older (Child, Adult, Older Adult)
Accepts Healthy Volunteers
N/A
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
The research database will hold data on adults who are treated by Portsmouth Hospitals University National Health Service Trust (PHU), either as an outpatient, Accident and Emergency (A&E) attender, day case or inpatient or have investigations carried out by PHU services Adult patients are defined by the National Health Service (NHS) as individuals over 16 years old.
Data on service contacts and use will only be included where the patient was more than 16 years old at that time.
None of the data included in the Clinical Outcomes analyses are collected specifically for the purposes of research.
All datasets are routinely collected clinical datasets, collected for clinical use and clinical audit.
Description
Inclusion Criteria:
- Adult presenting at the acute hospital or receiving services from the hospital
Exclusion Criteria:
- Adults who have registered an opt out of research with National Health Service (NHS) Digital
- Adults who have contacted the hospital to ask that their records are not to be included in this study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Retrospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
In-hospital death
Time Frame: At 24 hours after an observation assessment or physiological measurement
|
Death during hospital admission
|
At 24 hours after an observation assessment or physiological measurement
|
In-hospital death
Time Frame: 30 days after admission
|
Death during hospital admission
|
30 days after admission
|
Unanticipated ICU admission
Time Frame: At 24 hours after an observation assessment or physiological measurement
|
Unanticipated ICU admission during hospital stay
|
At 24 hours after an observation assessment or physiological measurement
|
Unanticipated ICU admission
Time Frame: 30 days after admission
|
Unanticipated ICU admission during hospital stay
|
30 days after admission
|
Cardiac arrest
Time Frame: At 24 hours after an observation assessment or physiological measurement
|
Cardiac arrest during hospital stay
|
At 24 hours after an observation assessment or physiological measurement
|
Cardiac arrest
Time Frame: 30 days after admission
|
Cardiac arrest during hospital stay
|
30 days after admission
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Diagnosis of Corona Virus Disease (COVID) infection
Time Frame: 48 hours after presentation
|
Diagnosis of COVID-19
|
48 hours after presentation
|
Diagnosis of Corona Virus Disease (COVID) infection
Time Frame: At 48 hours after an observation assessment or physiological measurement
|
Diagnosis of COVID-19
|
At 48 hours after an observation assessment or physiological measurement
|
Detection of Acute Organ Dysfunction
Time Frame: 24 hours after presentation
|
Detection of acute organ dysfunction as measured by components of the Sequential Organ Failure Assessment (SOFA) Score
|
24 hours after presentation
|
Detection of Acute Organ Dysfunction
Time Frame: 48 hours after presentation
|
Detection of acute organ dysfunction as measured by components of the Sequential Organ Failure Assessment (SOFA) Score
|
48 hours after presentation
|
Detection of Acute Organ Dysfunction
Time Frame: 72 hours after presentation
|
Detection of acute organ dysfunction as measured by components of the Sequential Organ Failure Assessment (SOFA) Score
|
72 hours after presentation
|
Detection of Acute Organ Dysfunction
Time Frame: 1 week after presentation
|
Detection of acute organ dysfunction as measured by components of the Sequential Organ Failure Assessment (SOFA) Score
|
1 week after presentation
|
Detection of Acute Organ Dysfunction
Time Frame: 30 days after presentation
|
Detection of acute organ dysfunction as measured by components of the Sequential Organ Failure Assessment (SOFA) Score
|
30 days after presentation
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Paul E Schmidt, MRCP, Portsmouth Hospitals University NHS Trust
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 19, 2021
Primary Completion (Anticipated)
April 1, 2026
Study Completion (Anticipated)
April 1, 2026
Study Registration Dates
First Submitted
June 23, 2021
First Submitted That Met QC Criteria
July 27, 2021
First Posted (Actual)
July 30, 2021
Study Record Updates
Last Update Posted (Actual)
April 7, 2023
Last Update Submitted That Met QC Criteria
April 6, 2023
Last Verified
April 1, 2023
More Information
Terms related to this study
Other Study ID Numbers
- PHU/2021/11
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
IPD Plan Description
Bona fides United Kingdom (UK) researchers can make requests for access.
They will be asked to detail their proposal in standard form which will be assessed by a Data Access Committee.
Data will only be made available in a fully anonymous form and will be subject to a data sharing agreement.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Adult Hospital Patients at Risk of Adverse Outcomes
-
Frederiksberg University HospitalCompleted
-
Wake Forest University Health SciencesCompletedUnplanned Hospital Readmissions | Patients at High Risk of Unplanned ReadmissionUnited States
-
Queen's University, BelfastCompletedPatients at High Risk of Medicine-related ProblemsUnited Kingdom
-
University Hospital, MontpellierNot yet recruitingPatients at High-Risk of a Cardiovascular Event
-
Weill Medical College of Cornell UniversityCompletedAmbulatory Care Patients Who Were Hospitalized in 2001 at the Cornell Campus of the New York-Presbyterian HospitalUnited States
-
Assiut UniversityUnknownEpidemiologic Data of Some Synthetic Cannibinoids Toxicity in Patients Presenting at Assiut University Hospital, Psychiatric Hospital of Ministry of Health) | Proportion of Acute and Chronic Abusers of Synthetic Cannibinoids Among Cases of Illicit Drugs Abuser in Studied SitesEgypt
-
Nantes University HospitalNot yet recruitingAdult Patients With Adverse Risk Acute Myeloblastic Leukemia
-
University Hospital of CologneKarolinska Institutet; University Hospital of North Norway; Goethe University; McGill... and other collaboratorsUnknownPatients at High Risk of Antibacterial Treatment Upon AdmissionGermany
-
Bioventus LLCEnrolling by invitationMitigation of Fracture Non-union in Patients at RiskUnited States
-
Mental Health Services in the Capital Region, DenmarkCopenhagen Trial Unit, Center for Clinical Intervention Research; Center for...CompletedPatients at Ultra-high Risk of PsychosisDenmark